Hong Kong College of Physicians Position Statement and Recommendations on the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension

The American College of Cardiology/American Heart Association released guidelines for the prevention, detection, evaluation, and management of high blood pressure (BP) in adults in 2017. In 2018, the European Society of Cardiology (ESC)/European Society of Hypertension (ESH) published new guidelines...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hong Kong Medical Journal 2020-10, Vol.26 (5), p.432-437
Hauptverfasser: Chan, KK, Szeto, CC, Lum, Christopher CM, Ng, PW, Kong, Alice PS, Lau, KP, Leung, Jenny YY, Lui, SL, Mo, KL, Mok, Francis CK, Mok, Vincent CT, Yan, Bryan PY, Li, Philip KT
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 437
container_issue 5
container_start_page 432
container_title Hong Kong Medical Journal
container_volume 26
creator Chan, KK
Szeto, CC
Lum, Christopher CM
Ng, PW
Kong, Alice PS
Lau, KP
Leung, Jenny YY
Lui, SL
Mo, KL
Mok, Francis CK
Mok, Vincent CT
Yan, Bryan PY
Li, Philip KT
description The American College of Cardiology/American Heart Association released guidelines for the prevention, detection, evaluation, and management of high blood pressure (BP) in adults in 2017. In 2018, the European Society of Cardiology (ESC)/European Society of Hypertension (ESH) published new guidelines for the management of arterial hypertension. Despite the many similarities between these two guidelines, there are also major differences in the guidelines in terms of diagnosis and treatment of hypertension. A working group of the Hong Kong College of Physicians (HKCP) convened and conducted a focused discussion on important issues of public interest, including classification of BP, BP measurement, thresholds for initiation of antihypertensive medications, BP treatment targets, and treatment strategies. The HKCP concurs with the 2018 ESC/ESH guideline on BP classification, which defines hypertension as office systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg. The HKCP also acknowledges the growing evidence of home BP monitoring and ambulatory BP monitoring in the diagnosis and monitoring of hypertension and endorses the wider use of both methods. The HKCP also supports the direction of a risk-based approach for initiation of antihypertensive medications and the specification of a treatment target range for both systolic and diastolic BP with consideration of different age-groups and specific disease subgroups. Non-pharmacological interventions are crucial, both at the societal and individual patient levels. The recent guideline publications provide good opportunities to increase public awareness of hypertension and encourage lifestyle modifications among the local population.
doi_str_mv 10.12809/hkmj198330
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2453683781</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2453683781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c331t-b9ddebc9db5132f2698507038aef0007cdd5b5ed8f3e7fcd421ba85cad5bb28c3</originalsourceid><addsrcrecordid>eNptkkFv2yAUx72pk5a1Pe0LIO0yqfL6gDjGxyhqm2mtWq3r2cLwnJDZkAE--NuXJFXXVr2A4P_j9x6CLPtK4QdlAqrz9d9-QyvBOXzMJoyxWS5KKI-yCQU2zVkJ4nP2JYQNABNFBZMPJ0tnV-TXbli4rsMVEteSu_UYjDLSBnLngonGWXIfZcQebSTSavIblevTSstdGEgC4hoJA1qSeY_eKGlfGhfSa-M6txrPn-MlSh_JPASXSu1r7MxJIcjF4N0WE3OfMozjG8V78XLcoo9ow050NRiNnbEYSOv8vrUbaeXqcIFEzxPqjexeHTvJPrWyC3j6NB9nD5cXfxbL_Pr26udifp0rzmnMm0prbFSlm4Jy1rJZJQoogQuJLQCUSuuiKVCLlmPZKj1ltJGiUDJtN0wofpx9P3i33v0bMMS6N0Fh10mLbgg1mxZ8JngpaEK_vUE3bvA2dVezQtD0iKKCRJ0dKOVdCB7beutNL_1YU6j3P6P-_zP4IyWEsV8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2581859890</pqid></control><display><type>article</type><title>Hong Kong College of Physicians Position Statement and Recommendations on the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Chan, KK ; Szeto, CC ; Lum, Christopher CM ; Ng, PW ; Kong, Alice PS ; Lau, KP ; Leung, Jenny YY ; Lui, SL ; Mo, KL ; Mok, Francis CK ; Mok, Vincent CT ; Yan, Bryan PY ; Li, Philip KT</creator><creatorcontrib>Chan, KK ; Szeto, CC ; Lum, Christopher CM ; Ng, PW ; Kong, Alice PS ; Lau, KP ; Leung, Jenny YY ; Lui, SL ; Mo, KL ; Mok, Francis CK ; Mok, Vincent CT ; Yan, Bryan PY ; Li, Philip KT</creatorcontrib><description>The American College of Cardiology/American Heart Association released guidelines for the prevention, detection, evaluation, and management of high blood pressure (BP) in adults in 2017. In 2018, the European Society of Cardiology (ESC)/European Society of Hypertension (ESH) published new guidelines for the management of arterial hypertension. Despite the many similarities between these two guidelines, there are also major differences in the guidelines in terms of diagnosis and treatment of hypertension. A working group of the Hong Kong College of Physicians (HKCP) convened and conducted a focused discussion on important issues of public interest, including classification of BP, BP measurement, thresholds for initiation of antihypertensive medications, BP treatment targets, and treatment strategies. The HKCP concurs with the 2018 ESC/ESH guideline on BP classification, which defines hypertension as office systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg. The HKCP also acknowledges the growing evidence of home BP monitoring and ambulatory BP monitoring in the diagnosis and monitoring of hypertension and endorses the wider use of both methods. The HKCP also supports the direction of a risk-based approach for initiation of antihypertensive medications and the specification of a treatment target range for both systolic and diastolic BP with consideration of different age-groups and specific disease subgroups. Non-pharmacological interventions are crucial, both at the societal and individual patient levels. The recent guideline publications provide good opportunities to increase public awareness of hypertension and encourage lifestyle modifications among the local population.</description><identifier>ISSN: 1024-2708</identifier><identifier>EISSN: 2226-8707</identifier><identifier>DOI: 10.12809/hkmj198330</identifier><language>eng</language><publisher>Hong Kong: Hong Kong Academy of Medicine</publisher><subject>Antihypertensives ; Blood pressure ; Cardiology ; Cardiovascular disease ; Classification ; Hypertension ; Lifestyles ; Older people ; Patients ; Physicians ; Risk factors</subject><ispartof>Hong Kong Medical Journal, 2020-10, Vol.26 (5), p.432-437</ispartof><rights>2020. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c331t-b9ddebc9db5132f2698507038aef0007cdd5b5ed8f3e7fcd421ba85cad5bb28c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Chan, KK</creatorcontrib><creatorcontrib>Szeto, CC</creatorcontrib><creatorcontrib>Lum, Christopher CM</creatorcontrib><creatorcontrib>Ng, PW</creatorcontrib><creatorcontrib>Kong, Alice PS</creatorcontrib><creatorcontrib>Lau, KP</creatorcontrib><creatorcontrib>Leung, Jenny YY</creatorcontrib><creatorcontrib>Lui, SL</creatorcontrib><creatorcontrib>Mo, KL</creatorcontrib><creatorcontrib>Mok, Francis CK</creatorcontrib><creatorcontrib>Mok, Vincent CT</creatorcontrib><creatorcontrib>Yan, Bryan PY</creatorcontrib><creatorcontrib>Li, Philip KT</creatorcontrib><title>Hong Kong College of Physicians Position Statement and Recommendations on the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension</title><title>Hong Kong Medical Journal</title><description>The American College of Cardiology/American Heart Association released guidelines for the prevention, detection, evaluation, and management of high blood pressure (BP) in adults in 2017. In 2018, the European Society of Cardiology (ESC)/European Society of Hypertension (ESH) published new guidelines for the management of arterial hypertension. Despite the many similarities between these two guidelines, there are also major differences in the guidelines in terms of diagnosis and treatment of hypertension. A working group of the Hong Kong College of Physicians (HKCP) convened and conducted a focused discussion on important issues of public interest, including classification of BP, BP measurement, thresholds for initiation of antihypertensive medications, BP treatment targets, and treatment strategies. The HKCP concurs with the 2018 ESC/ESH guideline on BP classification, which defines hypertension as office systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg. The HKCP also acknowledges the growing evidence of home BP monitoring and ambulatory BP monitoring in the diagnosis and monitoring of hypertension and endorses the wider use of both methods. The HKCP also supports the direction of a risk-based approach for initiation of antihypertensive medications and the specification of a treatment target range for both systolic and diastolic BP with consideration of different age-groups and specific disease subgroups. Non-pharmacological interventions are crucial, both at the societal and individual patient levels. The recent guideline publications provide good opportunities to increase public awareness of hypertension and encourage lifestyle modifications among the local population.</description><subject>Antihypertensives</subject><subject>Blood pressure</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Classification</subject><subject>Hypertension</subject><subject>Lifestyles</subject><subject>Older people</subject><subject>Patients</subject><subject>Physicians</subject><subject>Risk factors</subject><issn>1024-2708</issn><issn>2226-8707</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNptkkFv2yAUx72pk5a1Pe0LIO0yqfL6gDjGxyhqm2mtWq3r2cLwnJDZkAE--NuXJFXXVr2A4P_j9x6CLPtK4QdlAqrz9d9-QyvBOXzMJoyxWS5KKI-yCQU2zVkJ4nP2JYQNABNFBZMPJ0tnV-TXbli4rsMVEteSu_UYjDLSBnLngonGWXIfZcQebSTSavIblevTSstdGEgC4hoJA1qSeY_eKGlfGhfSa-M6txrPn-MlSh_JPASXSu1r7MxJIcjF4N0WE3OfMozjG8V78XLcoo9ow050NRiNnbEYSOv8vrUbaeXqcIFEzxPqjexeHTvJPrWyC3j6NB9nD5cXfxbL_Pr26udifp0rzmnMm0prbFSlm4Jy1rJZJQoogQuJLQCUSuuiKVCLlmPZKj1ltJGiUDJtN0wofpx9P3i33v0bMMS6N0Fh10mLbgg1mxZ8JngpaEK_vUE3bvA2dVezQtD0iKKCRJ0dKOVdCB7beutNL_1YU6j3P6P-_zP4IyWEsV8</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Chan, KK</creator><creator>Szeto, CC</creator><creator>Lum, Christopher CM</creator><creator>Ng, PW</creator><creator>Kong, Alice PS</creator><creator>Lau, KP</creator><creator>Leung, Jenny YY</creator><creator>Lui, SL</creator><creator>Mo, KL</creator><creator>Mok, Francis CK</creator><creator>Mok, Vincent CT</creator><creator>Yan, Bryan PY</creator><creator>Li, Philip KT</creator><general>Hong Kong Academy of Medicine</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BVBZV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20201001</creationdate><title>Hong Kong College of Physicians Position Statement and Recommendations on the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension</title><author>Chan, KK ; Szeto, CC ; Lum, Christopher CM ; Ng, PW ; Kong, Alice PS ; Lau, KP ; Leung, Jenny YY ; Lui, SL ; Mo, KL ; Mok, Francis CK ; Mok, Vincent CT ; Yan, Bryan PY ; Li, Philip KT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c331t-b9ddebc9db5132f2698507038aef0007cdd5b5ed8f3e7fcd421ba85cad5bb28c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antihypertensives</topic><topic>Blood pressure</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Classification</topic><topic>Hypertension</topic><topic>Lifestyles</topic><topic>Older people</topic><topic>Patients</topic><topic>Physicians</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, KK</creatorcontrib><creatorcontrib>Szeto, CC</creatorcontrib><creatorcontrib>Lum, Christopher CM</creatorcontrib><creatorcontrib>Ng, PW</creatorcontrib><creatorcontrib>Kong, Alice PS</creatorcontrib><creatorcontrib>Lau, KP</creatorcontrib><creatorcontrib>Leung, Jenny YY</creatorcontrib><creatorcontrib>Lui, SL</creatorcontrib><creatorcontrib>Mo, KL</creatorcontrib><creatorcontrib>Mok, Francis CK</creatorcontrib><creatorcontrib>Mok, Vincent CT</creatorcontrib><creatorcontrib>Yan, Bryan PY</creatorcontrib><creatorcontrib>Li, Philip KT</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>East &amp; South Asia Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Hong Kong Medical Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, KK</au><au>Szeto, CC</au><au>Lum, Christopher CM</au><au>Ng, PW</au><au>Kong, Alice PS</au><au>Lau, KP</au><au>Leung, Jenny YY</au><au>Lui, SL</au><au>Mo, KL</au><au>Mok, Francis CK</au><au>Mok, Vincent CT</au><au>Yan, Bryan PY</au><au>Li, Philip KT</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hong Kong College of Physicians Position Statement and Recommendations on the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension</atitle><jtitle>Hong Kong Medical Journal</jtitle><date>2020-10-01</date><risdate>2020</risdate><volume>26</volume><issue>5</issue><spage>432</spage><epage>437</epage><pages>432-437</pages><issn>1024-2708</issn><eissn>2226-8707</eissn><abstract>The American College of Cardiology/American Heart Association released guidelines for the prevention, detection, evaluation, and management of high blood pressure (BP) in adults in 2017. In 2018, the European Society of Cardiology (ESC)/European Society of Hypertension (ESH) published new guidelines for the management of arterial hypertension. Despite the many similarities between these two guidelines, there are also major differences in the guidelines in terms of diagnosis and treatment of hypertension. A working group of the Hong Kong College of Physicians (HKCP) convened and conducted a focused discussion on important issues of public interest, including classification of BP, BP measurement, thresholds for initiation of antihypertensive medications, BP treatment targets, and treatment strategies. The HKCP concurs with the 2018 ESC/ESH guideline on BP classification, which defines hypertension as office systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg. The HKCP also acknowledges the growing evidence of home BP monitoring and ambulatory BP monitoring in the diagnosis and monitoring of hypertension and endorses the wider use of both methods. The HKCP also supports the direction of a risk-based approach for initiation of antihypertensive medications and the specification of a treatment target range for both systolic and diastolic BP with consideration of different age-groups and specific disease subgroups. Non-pharmacological interventions are crucial, both at the societal and individual patient levels. The recent guideline publications provide good opportunities to increase public awareness of hypertension and encourage lifestyle modifications among the local population.</abstract><cop>Hong Kong</cop><pub>Hong Kong Academy of Medicine</pub><doi>10.12809/hkmj198330</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1024-2708
ispartof Hong Kong Medical Journal, 2020-10, Vol.26 (5), p.432-437
issn 1024-2708
2226-8707
language eng
recordid cdi_proquest_miscellaneous_2453683781
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals
subjects Antihypertensives
Blood pressure
Cardiology
Cardiovascular disease
Classification
Hypertension
Lifestyles
Older people
Patients
Physicians
Risk factors
title Hong Kong College of Physicians Position Statement and Recommendations on the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A40%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hong%20Kong%20College%20of%20Physicians%20Position%20Statement%20and%20Recommendations%20on%20the%202017%20American%20College%20of%20Cardiology/American%20Heart%20Association%20and%202018%20European%20Society%20of%20Cardiology/European%20Society%20of%20Hypertension%20Guidelines%20for%20the%20Management%20of%20Arterial%20Hypertension&rft.jtitle=Hong%20Kong%20Medical%20Journal&rft.au=Chan,%20KK&rft.date=2020-10-01&rft.volume=26&rft.issue=5&rft.spage=432&rft.epage=437&rft.pages=432-437&rft.issn=1024-2708&rft.eissn=2226-8707&rft_id=info:doi/10.12809/hkmj198330&rft_dat=%3Cproquest_cross%3E2453683781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2581859890&rft_id=info:pmid/&rfr_iscdi=true